David Byram
General Counsel bei BRAEBURN INC.
Aktive Positionen von David Byram
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
| BRAEBURN INC. | General Counsel | - | - |
Braeburn Pharmaceuticals SPRL
 Braeburn Pharmaceuticals SPRL Medical SpecialtiesHealth Technology Braeburn Pharmaceuticals SPRL develops and commercializes medical products. It’s a pharmaceutical company focused on novel, long-acting implantable and injectable therapies for serious neurological and psychiatric disorders, including addiction, pain, and schizophrenia. The firm offers Probuohine, CAM2038q1w, CAM2038q4w and Risperdone implant. The company was founded in 2012 and is headquartered in Road Town, British Virgin Islands. | General Counsel | - | - |
Karriereverlauf von David Byram
Ehemalige bekannte Positionen von David Byram
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
| OREXO AB | Corporate Officer/Principal | - | - |
| STAGEZERO LIFE SCIENCES LTD. | Corporate Officer/Principal | 12.07.2018 | - |
Ausbildung von David Byram
| Indiana University | Undergraduate Degree |
Statistik
International
| Vereinigte Staaten | 3 |
| Kanada | 2 |
| Schweden | 2 |
Operativ
| General Counsel | 2 |
| Corporate Officer/Principal | 2 |
| Undergraduate Degree | 1 |
Sektoral
| Health Technology | 4 |
| Consumer Services | 2 |
| Commercial Services | 2 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
| Börsennotierte Unternehmen | 2 |
|---|---|
| STAGEZERO LIFE SCIENCES LTD. | Health Technology |
| OREXO AB | Health Technology |
| Private Unternehmen | 2 |
|---|---|
Braeburn Pharmaceuticals SPRL
Braeburn Pharmaceuticals SPRL Medical SpecialtiesHealth Technology Braeburn Pharmaceuticals SPRL develops and commercializes medical products. It’s a pharmaceutical company focused on novel, long-acting implantable and injectable therapies for serious neurological and psychiatric disorders, including addiction, pain, and schizophrenia. The firm offers Probuohine, CAM2038q1w, CAM2038q4w and Risperdone implant. The company was founded in 2012 and is headquartered in Road Town, British Virgin Islands. | Health Technology |
Braeburn, Inc.
 Braeburn, Inc. Miscellaneous Commercial ServicesCommercial Services Braeburn, Inc. manufactures pharmaceutical products. It focuses on novel, long-acting implantable and injectable therapies for serious neurological and psychiatric disorders, including addiction, pain and schizophrenia. The firm develops Probuphine for the treatment of adult patients with opioid dependence. The company was founded in 2012 and is headquartered in Princeton, NJ. | Commercial Services |
- Börse
- Insiders
- David Byram
- Erfahrung
